Pharma & Bio
Technology
[Bio Spotlight] Biotech Stocks Rebound After 'Black Tuesday'… MedPacto, Inc. Rises, Two Days That Will Decide BioInfra Co.,Ltd.’s Fate
On the 28th, dubbed “Black Tuesday,” some biotech stocks hit their daily price limit. On a day when the KOSDAQ market plummeted, Cellid Co., Ltd.(299660), BioInfra Co.,Ltd.(199730), and MedPacto, Inc.…
Lifestyle
[Exclusive] Ingenia Puts New Kidney Drug on the Table for Technology Export... Hints at a “Trillion-Won” Mega Deal
Ingenia Therapeutics (Ingenia), an innovative antibody drug developer set to list on KOSDAQ, has brought a treatment for chronic kidney disease (CKD) to the negotiating table with a global big pharma …
Lifestyle
Biotech Startups’ Risky Moves… Why the “Build First, Then Lease” Formula Persists
There have been repeated instances of domestic biotech startups building factories even before product development is complete or before signing contracts with global companies. However, contrary to e…
Technology
Park Young-kyu, CEO of BRP Connect: "Pharmaceutical Data Is Our Weapon… We Will Build a Homegrown Platform That Surpasses IQVIA"
South Korea’s pharmaceutical and biotech industry is entering an era of “data competition.” A company’s ability to respond to market dynamics hinges on how quickly and accurately it can analyze trends…
Technology
i-SENS Soars on Earnings, Peptron Rebounds, Cellid Hits Limit-Up [K-Bio Pulse]
South Korean pharmaceutical and biotechnology stocks were mixed on Monday, with i-SENS soaring after reporting second-quarter earnings that far exceeded market expectations, Peptron extending its rebo…
Technology
[Bio Spotlight] i-SENS, Inc. Rises 9% on ‘Earnings Surprise’… Peptron, Inc. and Cellid Co., Ltd. Also Soar
On the 27th, in the domestic pharmaceutical and biotech stock market, i-SENS, Inc.(099190)saw its stock price surge after reporting second-quarter earnings that significantly exceeded market expectati…
Technology
Kolon TissueGene Avoids Fourth Consecutive Limit-Down; Peptron Jumps in After-Hours Trading [K-Bio Pulse]
South Korea’s biotech sector showed sharp divergence on July 24. Kolon TissueGene narrowly avoided a fourth consecutive limit-down close, while Peptron surged in after-hours trading on expectations fo…
Technology
Kolon TissueGene, Inc. Falls for 4 Consecutive Days… Why Did Peptron, Inc. Surge in After-Hours Trading? [Bio Spotlight]
On the 24th, in the biotech sector, Kolon TissueGene, Inc. narrowly avoided hitting the daily price limit down for the fourth consecutive trading day. Peptron, Inc. saw its stock price show strength i…
Lifestyle
Huino Expected to Surpass 15 Billion Won in Annual Sales as It Steps Up Sales of Yuhan Corporation’s ‘Memo Q’
Yuhan(000100), a strategic investor (SI) and distribution partner of Huino, a leading digital healthcare company, has significantly expanded its purchase volume of new in-hospital monitoring solutions…
Technology
Celltrion Enters Era of 60% Revenue from New Products... Full-Scale Efforts to Diversify Revenue and Boost Profitability Underway
Celltrion(068270)Analysts note that as the company reduces its reliance on “Remsima” and expands its product portfolio with high-margin products, revenue diversification and profitability growth are g…